V. Haynes

发表

A network meta-analysis of atomoxetine and osmotic release oral system methylphenidate in the treatment of attention-deficit/hyperactivity disorder in adult patients

V. Reed, A. Pitcher, C. Bushe, 2016, Journal of psychopharmacology.

Digital Tracking of Rheumatoid Arthritis Longitudinally (DIGITAL) Using Biosensor and Patient-Reported Outcome Data: Protocol for a Real-World Study

J. Curtis, D. Faries, J. Poon, 2019, JMIR research protocols.

Diagnosis, treatment, and burden of illness among adults with attention-deficit/hyperactivity disorder in Europe

S. Able, V. Haynes, Jihyung Hong, 2014, Pragmatic and observational research.

Healthcare utilization and costs of children with attention deficit/hyperactivity disorder initiating atomoxetine versus extended-release guanfacine

C. Alatorre, D. Faries, A. Nyhuis, 2018, Current medical research and opinion.

Patient characteristics associated with treatment initiation among paediatric patients with Attention-Deficit/Hyperactivity Disorder symptoms in a naturalistic setting in

J. Haro, T. Treuer, W. Montgomery, 2014 .

PMH2 Interim Results From the “AUTOR” Study, a European Observational Study in Pediatric Patients With Attention Deficit/Hyperactivity Disorder: Patient Characteristics and 1-Year Costs

M. Lorenzo, V. Haynes, D. Quail, 2012 .

Does Placebo Response Differ between Objective and Subjective Measures in Children with Attention-Deficit/Hyperactivity Disorder?

Martin H. Teicher, J. Newcorn, C. Sumner, 2010, Postgraduate medicine.

Long-term healthcare costs and functional outcomes associated with lack of remission in schizophrenia: a post-hoc analysis of a prospective observational study

H. Ascher-Svanum, B. Kinon, Baojin Zhu, 2012, BMC Psychiatry.

Cost Effectiveness of Guanfacine Extended-Release Versus Atomoxetine for the Treatment of Attention-Deficit/Hyperactivity Disorder: Application of a Matching-Adjusted Indirect Comparison

C. Alatorre, H. Upadhyaya, D. Faries, 2013, Applied Health Economics and Health Policy.

Retrospective assessment of patient characteristics and healthcare costs prior to a diagnosis of Alzheimer’s disease in an administrative claims database

A. Fleisher, M. Witte, M. Siadaty, 2018, BMC Geriatrics.

Combination Therapy Patterns and Predictors of ADHD in Commercially Insured and Medicaid Populations

A. Farr, C. Molife, D. Kelsey, 2012, Postgraduate medicine.

The Effectiveness of a Private Orthopaedic Practice-Based Osteoporosis Management Service to Reduce the Risk of Subsequent Fractures

A. Araujo, O. Baser, Clifford B. Jones, 2018, The Journal of bone and joint surgery. American volume.

Differences in maintenance of response upon discontinuation across medication treatments in attention-deficit/hyperactivity disorder

J. Buitelaar, P. Asherson, H. Upadhyaya, 2015, European Neuropsychopharmacology.

COMPREHENSIVE REVIEW OF FACTORS IMPLICATED IN THE HETEROGENEITY OF RESPONSE IN DEPRESSION

L. Marangell, C. Alatorre, I. Goetz, 2012, Depression and anxiety.

Non-negative matrix factorization of multimodal MRI, fMRI and phenotypic data reveals differential changes in default mode subnetworks in ADHD

Alan L. Yuille, Ying Nian Wu, Mark S. Cohen, 2014, NeuroImage.

Patient characteristics associated with treatment initiation among paediatric patients with Attention-Deficit/Hyperactivity Disorder symptoms in a naturalistic setting in Central Europe and East Asia

J. Haro, T. Treuer, W. Montgomery, 2014, BMC Psychiatry.

Predictors and consequences of adherence to the treatment of pediatric patients with attention-deficit/hyperactivity disorder in Central Europe and East Asia

J. Haro, T. Treuer, W. Montgomery, 2013, Patient preference and adherence.

Attention-deficit/hyperactivity disorder Under Treatment Outcomes Research (AUTOR): a European observational study in pediatric subjects

P. López-Romero, E. Anand, V. Haynes, 2015, ADHD Attention Deficit and Hyperactivity Disorders.

Movement disorder profile and treatment outcomes in a one-year study of patients with schizophrenia

K. Schuh, H. Ascher-Svanum, B. Kinon, 2013, Neuropsychiatric disease and treatment.

Health state utilities associated with adult attention-deficit/hyperactivity disorder

L. Matza, J. Jordan, E. Davies, 2014, Patient preference and adherence.

Digital Tracking of Rheumatoid Arthritis Longitudinally (DIGITAL) Using Biosensor and Patient-Reported Outcome Data: Protocol for a Real-World Study (Preprint)

J. Curtis, D. Faries, J. Poon, 2019 .